The BBC argues for novel catheters; WSJ calls for better in-home tech;

@FierceMedDev: ICYMI: Quest and Quintiles rev up new lab testing JV. FierceDiagnostics story | Follow @FierceMedDev

@VarunSaxena2: Greek referendum: Next big deadline is payment to ECB (assuming no bank run). Sad & ironic that technocrats still have to make this decision. | Follow @VarunSaxena2

@EmilyWFierce: A Perfect Blood Test For Pancreatic Cancer? Forbes story | Follow @EmilyWFierce

> Private equity firm RoundTable Healthcare Partners has purchased acute care medical product company TIDI Products for an undisclosed sum. More

> The BBC has run a commentary arguing for innovative catheters, including the use of novel materials, as well as a reduction in their use to improve the patient experience and help avoid infection. Article

> Similarly, The Wall Street Journal has a blog arguing for more and better applications of technology to at-home caregiving. Blog

Biotech News

@FierceBiotech: Analyst Schoenebaum offers best-case scenario for Axovant's 4-time Alzheimer's loser. More | Follow @FierceBiotech

@JohnCFierce: The dog that didn't bark? Odd that $AXON trolls haven't been on my tail. Where are the die-hard fanatics? Is this mostly an insiders' game? | Follow @JohnCFierce

> 23andMe raises $79M as it ramps up R&D work. Item

> Novo Nordisk backs out of a diabetes deal with Zosano. Story

> Versartis gets out from under the FDA with its growth hormone treatment. Article

Pharma News

@FiercePharma: USDA amends rules to allow vets to make custom vaccines in their offices. FierceAnimalHealth story | Follow @FiercePharma

@EricPFierce: Don't miss our July 8 Twitter chat on sustained release with BASF expert Thorsten Cech. Details are here | Follow @EricPFierce

@CarlyHFierce: ICYMI from FiercePharmaMarketing: Bayer draws up big sales plans for ex-Merck OTC meds. Story | Follow @CarlyHFierce

> Hospira's Remicade biosimilar wins large French contract with deep discount. More

> Sanofi and Gilead set sail to Japan with new approvals for Toujeo, Harvoni. Article

Pharma Marketing News

> Hot summer ad wars: Celgene launches Otezla DTC into crowded psoriasis drug market. More

> Sanofi, Regeneron break out the popcorn for cholesterol-fighting, PCSK9-friendly documentary. Story

> Expecting payer pushback, Vertex to field new CF med Orkambi at $259K. Article

> Dry-eye expert Allergan bets $125M on Oculeve and its new implant approach. Item

> Hotel workers lobby to stop Big Pharma funding for CME. More

Animal Health News

> Flu season over? Not for dogs. Item

> Patterson offloads medical unit to private equity firm for $715M, boosts focus on animal health. Report

> Report: With Valeant takeover rumors fading, could Zoetis buy IDEXX? More

> USDA amends rules to allow vets to make custom vaccines in their offices. Story

> FDA, Gates Foundation call for improved global access to veterinary drugs. Article

Biotech IT News

> Broad Institute snaps up GemCode Platform as 10X Genomics starts shipping. News

> Novartis steps into wearables with app for Apple Watch, Android Wear. More

> Mousera bags $20M VC round to advance sensor tech in preclinical research. Story

> BioClinica mounts European expansion to push imaging and eClinical. Article

> Congressman pushes to unshackle pharma on social media. Report

Suggested Articles

Millions of tests are urgently needed as the virus keeps communities across the country in lockdown and hospitals are overwhelmed with patients.

The FDA granted its first emergency authorization for a rapid antibody blood test for COVID-19 developed by Cellex.

The ultimate goal is to move as many patients as possible out of the clinic that don’t need immediate, critical care.